Abstract: Introduction: Systemic inflammatory activity plays a key role in the pathogenesis and progression of atherosclerosis in subjects with type 2 diabetes. Hence evaluation of inflammatory novel biomarkers like high-sensitivity C-reactive protein and ferritin serves as tools for cardiovascular risk prediction. Objectives: to evaluate the levels of high-sensitivity C-reactive protein (hs-CRP), ferritin& glycated haemoglobin in controls and type 2 diabetic subjects and to assess the correlations if any, between fasting serum glucose, hs-CRP, ferritin& glycated haemoglobin. Materials and Methods: A total number of 100 subjects were studied, comprising of 50 controls and 50 type 2 diabetic subjects. Diabetic subjects were further divided depending upon treatment modalities. Serum levels of hs-CRP, ferritin were measured by Chemiluminescense Immunoassay. Glycated haemoglobin was measured by Nephelometry. The statistical analysis was carried out using student't' test and Karl Pearson's coefficient of correlation. Results: hs-CRP, ferritin & glycated haemoglobin levels were found to be significantly increased (p<0.01) in type 2 diabetic subjects compared to controls. There was highly significant (P<0.01) positive correlations existed between fasting serum glucose, hs-CRP and HbA1c. Discussion & Conclusion: Elevated levels of hs-CRP and ferritin predict the future cardiovascular complications in type 2 diabetic subjects. Glycated haemoglobin serves as a simple and rapid biomarker to assess glycemic control in type 2 diabetic subjects. The current study demonstrates that higher HbA1c levels are significantly associated with elevation of hs-CRP. These results imply a significant relation between glycemic control, inflammation and cardiovascular risk.
Introduction
Diabetes Mellitus, a Dysglycemic Metabolic Syndrome refers to a group of common metabolic disorders that share phenotype of hyperglycemia, due to reduced insulin secretion, decreased glucose utilization and increased glucose production. 1 The Hindu physicians Sushrutha and Charaka wrote between 400-500 BC were probably first to recognize sweetness of Diabetic urine. Indeed the diagnosis was made by tasting the urine or noting that ants congregated round it. They noted that the disease was most prevalent in those who were indolent, overweight and gluttonous who indulged in sweet and fatty foods. 2 The prevalence of Diabetes has shown increasing trend in the last three decades in India. Currently the total number of people with Diabetes India is 61.3 million and is expected to increase to 101.2 million by 2030. 3 Systemic inflammatory activity plays a key role in the pathogenesis of vascular atherosclerosis, insulin resistance and type 2 diabetes mellitus. Inflammatory biomarkers may therefore be a valuable tool for risk evaluation. Among them, the best evidence to date supports the use of hs-CRP as an independent predictor of increased cardiovascular disease risk in diabetic and non diabetic subjects. C-reactive protein is an acute phase protein synthesized by the liver found in circulation in response to low grade inflammationand plasma levels of hs-CRP provide a sensitive marker of an increased inflammatory activity in the arterial wall. 4 Ferritin is a storage form of iron found in nearly all the cells of the body. The increased levels of ferritin in the blood reflect both the involvement of inflammation and independent actions of excess iron. It is known that increased accumulation of iron affects insulin synthesis and secretion in the pancreas and interferes with insulinextracting capacity of the liver leading to hyperinsulinemia, impaired insulin secretion, insulin resistance and diabetes. 5 In 1976, the HbA1c (Glycated hemoglobin), test was introduced as a monitor of glycemic control. Glycated hemoglobin is formed when aldehyde group of glucose and some other hexoses combine irreversibly, posttranslationally, non-enzymatically with N-terminal valine residues of each β-chain of hemoglobin and this process is substrate concentration dependent Measurement of HbA1c is considered as gold standard for monitoring chronic glycemia in Diabetic patients. Hence monitoring glycemic status has been considered as cornerstone of diabetic control. 6 Under aseptic precautions about 6 mL of fasting venous blood was drawn from ante-cubital vein of study subjects using a sterile disposable syringe. Of that, 4 mL was collected in plain vacutainer and 2 mL into EDTA containing vacutainer. Plain vacutainer containing 4 mL of blood was subjected for centrifugation and the serum was separated. The biochemical parameters were analyzed by Chemiluminescense immunoassay and Nephelometry.
Objectives

e) Parameters measured:
In the present study following parameters were estimated. I. Serum was used for the estimation of following parameters 1) Fasting serum glucose, 2) High Sensitivity C-reactive protein,
II. Whole blood was used for the estimation of Glycated hemoglobin Based on inclusion and exclusion criteria, age and sex matched controls and cases are included in the present study after obtaining informed consent. A proforma was used to record relevant information and patient's data. Serum concentration of glucose was estimated by glucose oxidase method 7 using analytical kits from Erba Diagnostics Mannheim GmbH in semi-autoanaylzer (CHEM-5 Plus V 2 , Erba Mannheim). Serum concentrations of hs-CRP, ferritin were estimated by Chemiluminescense immunoassay 8, 9 (CLIA) kits from Acculite Monobind in Lumax CLIA strip reader.Glycated hemoglobin was estimated by Nephelometry 10 kits from Agappe in MISPA-i card reader.
f) Statistical Analysis
Mean and standard deviations were used to describe the data. Students't' test was used for comparison between controls and study subjects. Relationship between variables was assessed by Karl Pearson's coefficient of correlation. Pvalue of 0.05 or less was considered as statistically significant. A total of number of 100 subjects were included in the study. Among them, 50 were cases with type 2 diabetes mellitus and 50 were age and sex matched controls.Among the 50 controls studied, 35 were males and 15 were females with a mean age of 44.5 ± 7.8 years. Among the 50 type 2 diabetic subjects studied, 38 were males and 12 were females with mean age of 45.6 ± 6.7 years It shows the diagnostic validity of glycated hemoglobin levels for glycemic control with cut-off level as 6.9%. It is evident that the glycated hemoglobin has the sensitivity of 90%, specificity of 94%, positive predictive value of 93.7%, negative predictive value of 90.3% and accuracy of 92% for predicting level of glycemic control.
Discussion
Diabetes mellitus is the commonest endocrine disorder. Systemic inflammatory activity plays a key role in the pathogenesis of vascular atherosclerosis, insulin resistance and type 2 diabetes mellitus. Inflammatory biomarkers may be of valuable tool for risk evaluation. Among them best evidence to date supports the use of high-sensitivity Creactive protein to monitor cardiovascular risk in diabetic and nondiabetic individuals. 4 In the present study we had evaluated 100 subjects including 50 controls and 50 type 2 diabetic subjects. Of the 50 type 2 diabetic subjects, 38 were males and 12 were females and among controls, 35 were males and 15 were females.
We studied high-sensitivity C-reactive protein, ferritin and glycated hemoglobin levels in controls and type 2 diabetic subjects.
The mean ± SDs of fasting serum glucose in controls and type 2 diabetic subjects were in the range of 90.96 ± 9.61 mg/dL and 150.17 ± 23.67 mg/dL, respectively. The mean value of fasting serum glucose was higher in type 2 diabetic subjects compared to controls. The increase is found to be statistically highly significant (p <0.001) which is in accordance with Amanullah S et al 11 , Mahajan A et al 12 & Meshram A et al. 13 Hyperglycemia in DM is caused by both overproduction and underutilization of glucose. There is a relative excess of glucagon also. As a consequence, glucose production is increased rather than consumption by liver, and also there is drastic reduction of uptake of glucose into muscle and adipose tissue finally contributing to hyperglycemia. 14 The mean ± SDs of hs-CRP in controls and type 2 diabetic subjects were in the range of 1.79 ± 1.01 mg/L and 13.15 ± 15.74 mg/L, respectively. The mean value of hs-CRP in type 2 diabetic subjects was higher when compared to controls.
The increase was found to be statistically highly significant (p <0.001). This is in accordance with Ridkar M.P 15 , Chamber J.C et al 16 &Coban E 17 .It was also observed that hs-CRP levels positively correlated with fasting serum glucose and glycated hemoglobin which is in accordance with Wu T et al 18 and King D.E et al 19 Some investigators hypothesized that decreased insulin sensitivity may lead to enhanced CRP expression by counteracting the physiological effect of insulin on hepatic acute-phase protein synthesis.Clamp studies in normal subjects showed that insulin exerts selective effects on hepatic protein synthesis, reducing the expression of acutephase response proteins. Resistance to this effect would in turn lead to increased synthesis of acute-phase proteins such as CRP.
Large prospective studies pointed out the involvement of increased hs-CRP on cardiovascular morbidity and mortality. High levels of hs-CRP have been shown to be an independent predictor of cardiovascular risk for all degrees of severity of metabolic syndrome and type 2 diabetes. 4 In hyperglycemic condition the concentration of advanced glycation end products is elevated that has been shown to activate macrophages, increase oxidative stress and upregulate synthesis of interleukin-1 (IL-1), IL-6 and tumour necrosis factor (TNF-α) resulting in production of CRP. The mean ± SDs of ferritin in controls and type 2 diabetic subjects were in the range of 101.55 ± 78.76 ng/mL and 263.34 ± 82.65 ng/mL respectively. The mean value of ferritin in type 2 diabetic subjects was higher when compared to controls. The increase was found to be statistically highly significant (p <0.001). This is in accordance with the Ford E.S 22 . In the present study we also found positive correlation existed between ferritin and HbA 1c in type 2 a diabetic subject which was statistically not significant. Ferritin is one of the key proteins regulating iron homeostasis, is widely available clinical biomarker to evaluate iron status. However, growing evidence has shown that even moderately increased iron stores represented by high-normal ferritin concentrations are associated with diabetes. 23 At least three possible explanations may account for elevated ferritin concentrations in patients with diabetes. Strength and further scope of the study: This study demonstrates that the high levels of hs-CRP and ferritin as biomarkers for predicting cardiovascular complications in type 2 diabetes.The study also considers inclusion of interleukins (IL-1 & IL-6) as additional biomarkers in large number of subjects in future studies to decrease the variability's in data and to have a highly statistical significance.
Conclusion
Diabetes mellitus is an important health problem prevailing across the globe. Inflammation plays a significant role in the pathogenesis of diabetes and its associated complications. Evaluation of inflammatory biomarkers like high-sensitivity C-reactive protein and ferritin help in assessing cardiovascular risk. There is significant elevation in the levels of high-sensitivity C-reactive protein, ferritin, insulin, glycated hemoglobin, in type 2 diabetic subjects as compared to controls. There is strong association found between fasting serum glucose, high-sensitivity C-reactive protein and glycated hemoglobin. According to our results together with previous other studies findings, we suggest that the quantitative determination of high-sensitivity Creactive protein and ferritin help in predicting type 2 diabetes mellitus associated cardiovascular complications.Glycated hemoglobin provides a retrospective index of glucose control over a time in Diabetic subjects. Measurement of glycated hemoglobin serves as a simple and rapid procedure to assess glycemic control. It serves both as a screening test for control of diabetes and as an indicator of efficacy of treatment. Thus the study concluded that inflammatory biomarkers like high-sensitivity C-reactive protein and ferritin are strongly and independently associated with cardiovascular complications in diabetes. In addition regular exercises and effective administration of anti-inflammatory agents may offer protection against type 2 diabetes mellitus associated complications.
